**Core Concept:** Nucleotide derivatives are a class of medications that modulate the immune response and reduce the risk of organ rejection after transplantation. They act by inhibiting the activity of enzymes involved in purine synthesis and degradation, thereby decreasing the production of cytokines and reducing inflammation.

**Why the Correct Answer is Right:** The correct answer, C. Mycophenolic acid (Myfortic), is a potent inhibitor of inosine monophosphate dehydrogenase (IMPDH) enzyme. IMPDH is a key enzyme in the de novo purine synthesis pathway. By inhibiting this enzyme, mycophenolic acid suppresses lymphocyte proliferation, reduces inflammation, and prevents organ rejection in transplant patients.

**Why Each Wrong Option is Incorrect:**

A. Cyclosporine (Neoral): This is an immunosuppressive drug that works by inhibiting calcineurin, a calcium-dependent enzyme involved in the activation of T-cells. Cyclosporine does not target the purine synthesis pathway.

B. Azathioprine (Imuran): This drug inhibits the enzyme 5'-nucleotidase, which is involved in purine degradation. However, azathioprine does not significantly inhibit IMPDH, making it an inferior choice compared to mycophenolic acid.

D. Tacrolimus (Prograf): This is another immunosuppressive drug that works by inhibiting calcineurin. It is not a nucleotide derivative and does not target the purine synthesis pathway.

**Clinical Pearl:** Mycophenolic acid is a potent immunosuppressive agent used to prevent organ rejection in transplant patients. By inhibiting IMPDH, it reduces lymphocyte proliferation and inflammation, thereby preserving the graft function and preventing organ rejection.